Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review
Oncology Today with Dr Neil Love
00:00
YAHIT‑1 Eligibility and Purpose
Hanny explains YAHIT-1 enrolls most primary ITP patients to test early intervention, safety, and potential disease modification.
Play episode from 01:07
Transcript
